Tarsons Products Q2FY27 Results: Strong Revenue Growth Offset by Margin Pressures
Tarsons Products Ltd · Investor Presentation · 13 Nov 2026, 5:49 am
Tarsons Products Q2FY27 Results: Strong Revenue Growth Offset by Margin Pressures Tarsons Products reported a 20.8% YoY rise in consolidated Q2FY27 revenue to ₹123.7 cr, led by standalone domestic growth of 18.6% and export expansion of 36.8%. However, higher raw material costs and expenses from newly commissioned facilities compressed consolidated EBITDA margins by 170 bps YoY to 25.1% (EBITDA at ₹31.1 cr). Elevated depreciation and finance charges resulted in a consolidated net loss of ₹0.3 cr versus a profit of ₹3.3 cr in Q2FY26. Commercial operations at Panchla's cell culture lines are slated for H2FY27.
Original exchange filing (PDF)
More announcements from Tarsons Products Ltd
- Intimation of Audio Recording of Conference Call for the quarter and half year ended September 30, 2026 · 13 Nov 2026
- Intimation of Schedule of Analyst/Institutional Investor Meeting(s) · 12 Nov 2026
- Tarsons Products Limited has informed the Exchange about General Updates · 12 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 · 12 Nov 2026
- Tarsons Products Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 12 Nov 2026
- Outcome of the Board meeting, approving the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026. · 12 Nov 2026
- Intimation of Schedule of Investor/Analyst Conference Call to discuss the financial and operational performance for the quarter and half year ended September 30, 2026 · 13 Nov 2026
- Tarsons Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the Unaudited Standalone and .... · 12 Nov 2026
